PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google has expanded NotebookLM to allow sharing of notebooks, and more importantly, access to curated collections from ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

A chief economist at investment giant Apollo says the top ten AI stocks are more detached from reality than the tech titans ...

JSS AHER collaborates with Google Research to evaluate AI tool AMIE in text-based consultations, enhancing healthcare solutions and academic leadership.

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...